Neurol. praxi. 2021;22(2):91-92 | DOI: 10.36290/neu.2020.122

Zriedkavé neuromuskulárne choroby

doc. MUDr. Peter Špalek, PhD.
Národné expertízne centrum pre zriedkavé neuromuskulárne ochorenia, Neurologická klinika SZU a UNB, Nemocnica Ružinov, Bratislava
Sekcie pre neuromuskulárne ochorenia, Slovenská neurologická spoločnosť

Received: December 2, 2020; Revised: December 2, 2020; Accepted: December 8, 2020; Prepublished online: December 8, 2020; Published: April 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špalek P. Zriedkavé neuromuskulárne choroby. Neurol. praxi. 2021;22(2):91-92. doi: 10.36290/neu.2020.122.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benarroch L, Bonne G, Rivier F, Hamroun D. The 2021 version of the gene table of neuromuscular disorders (nuclesr genome). Neuromusc Disord 2020; 30: 1008-1048. Go to original source... Go to PubMed...
    2. Gilhus NE, Verschuuren J. Masthenia gravis: subgroup classification an therapeutic strategies. Lancet Neurol 2015; 14: 1023-1026. Go to original source... Go to PubMed...
    3. Hrčková G. Zriedkavé choroby a Orphanet. Neurol praxi. 2021; 22(2): 93-99. Go to original source...
    4. Sosková M, Špalek P. Nová klasifikácia pletencových muskulárnych dystrofií. Neurológia 2021; 16: 21-23.
    5. Špalek P. Orphan drugs v liečbe zriedkavých neuromuskulárnych chorôb. Neurol. praxi 2021; 22(2): 104-112. Go to original source...
    6. Straub V, Murphy A, Udd B. LGMD workshop group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification. Naarden, The Netherlands, 17-19 March 2017. Neuromusc Disord 2018; 28: 702-710. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.